Andreas Schibler

Andreas Schibler

Auto-generated profile, based on publicly available information

Andreas Schibler

Paediatric Critical Care Research Group, Lady Cilento Children's Hospital, Brisbane, Queensland, Australia

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2016 in Thorax
Verified
Journal Article
Open access
PDF file
IFInéz Frerichs
Inéz Frerichs
MAMarcelo B P Amato
Marcelo B P Amato
AKAnton H van Kaam
Anton H van Kaam
DTDavid G Tingay
David G Tingay
Zhanqi ZhaoZhanqi Zhao
Zhanqi Zhao
TGTREND study group
TREND study group
Electrical impedance tomography (EIT) has undergone 30 years of development. Functional chest examinations with this technology are considered clinically relevant, especially for monitoring regional lung ventilation in mechanically ventilated patients and for regional pulmonary function testing in patients with chronic lung diseases. As EIT becomes an established medical technology, it requires consensus examination, nomenclature, data analysis and interpretation schemes. Such consensus is needed to compare, understand and reproduce study findings from and among different research groups, to enable large clinical trials and, ultimately, routine clinical use. Recommendations of how EIT findings can be applied to generate diagnoses and impact clinical decision-making and therapy planning are required. This consensus paper was prepared by an international working group, collaborating on the clinical promotion of EIT called TRanslational EIT developmeNt stuDy group. It addresses the stated needs by providing (1) a new classification of core processes involved in chest EIT examinations and data analysis, (2) focus on clinical applications with structured reviews and outlooks (separately for adult and neonatal/paediatric patients), (3) a structured framework to categorise and understand the relationships among analysis approaches and their clinical roles, (4) consensus, unified terminology with clinical user-friendly definitions and explanations, (5) a review of all major work in thoracic EIT and (6) recommendations for future development (193 pages of online supplements systematically linked with the chief sections of the main document). We expect this information to be useful for clinicians and researchers working with EIT, as well as for industry producers of this technology.

22 March 2018 in New England Journal of Medicine
Verified
Journal Article
Closed access
DFDonna Franklin
Donna Franklin
FBFranz E. Babl
Franz E. Babl
LSLuregn J. Schlapbach
Luregn J. Schlapbach
EOEd Oakley
Ed Oakley
SCSimon Craig
Simon Craig
ASAndreas Schibler
Andreas Schibler
High-flow oxygen therapy through a nasal cannula has been increasingly used in infants with bronchiolitis, despite limited high-quality evidence of its efficacy. The efficacy of high-flow oxygen therapy through a nasal cannula in settings other than intensive care units (ICUs) is unclear.

1 January 2015 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
LSLuregn J Schlapbach
Luregn J Schlapbach
LSLahn Straney
Lahn Straney
JAJanet Alexander
Janet Alexander
GMGraeme MacLaren
Graeme MacLaren
MFMarino Festa
Marino Festa
ASAnthony Slater
Anthony Slater

3 March 2011 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
ASA. Schibler
A. Schibler
TPT. M. T. Pham
T. M. T. Pham
KDK. R. Dunster
K. R. Dunster
KFK. Foster
K. Foster
ABA. Barlow
A. Barlow
JHJ. L. Hough
J. L. Hough

1 February 2017 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
SHS Humphreys
S Humphreys
PLP Lee-Archer
P Lee-Archer
GRG Reyne
G Reyne
DLDebbie Long
Debbie Long
TWT Williams
T Williams
ASA Schibler
A Schibler
Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) was introduced to adult anaesthesia to improve the safety of airway management during apnoea before intubation. The objective of our study was to determine whether THRIVE safely prolongs apnoeic oxygenation in children. This was a randomized controlled trial in 48 healthy children, with normal airways and cardiorespiratory function, in age groups 0-6 and 7-24 months, 2-5 and 6-10 yr old, presenting for elective surgery or imaging under general anaesthesia. All children were induced with sevoflurane, O2, and N2O, followed by muscle relaxation with rocuronium, and standardized preoxygenation with bag-and-mask ventilation. The control arm received jaw support during apnoea, whereas the THRIVE arm received jaw support during apnoea and age-specific flow rates. The primary outcome was to demonstrate that children allocated to THRIVE maintain transcutaneous haemoglobin saturation at least twice as long as the expected age-dependent apnoea time in the control group. Both study arms (each n=24) were similar in age and weight. The apnoea time was significantly shorter in the control arm: average 109.2 (95% CI 28.8) s in the control arm and 192 s in the THRIVE arm (0-6 months), 147.3 (95% CI 18.9) and 237 s (7-24 months), 190.5 (95% CI 15.3) and 320 s (2-5 yr), and 260.8 (95% CI 37.5) and 430 s (6-10 yr), respectively. Average transcutaneous haemoglobin saturation remained at 99.6% (95% CI 0.2) during THRIVE. Transcutaneous CO2 increased to a similar extent in both arms, with 2.4 (95% CI 0.5) mm Hg min-1 for the control arm and 2.4 (95% CI 0.4) mm Hg min-1 for the THRIVE arm. Transnasal humidified rapid-insufflation ventilatory exchange prolongs the safe apnoea time in healthy children but has no effect to improve CO2 clearance. ACTRN12615001319561.

1 May 2007 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
SESimon Erickson
Simon Erickson
ASAndreas Schibler
Andreas Schibler
ANAndrew Numa
Andrew Numa
GNGabrielle Nuthall
Gabrielle Nuthall
MYMichael Yung
Michael Yung
BWBarry Wilkins
Barry Wilkins
Acute lung injury (ALI) is poorly defined in children. The objective of this prospective study was to clarify the incidence, demographics, management strategies, outcome, and mortality predictors of ALI in children in Australia and New Zealand. Multicenter prospective study during a 12-month period. Intensive care unit. All children admitted to intensive care and requiring mechanical ventilation were screened daily for development of ALI based on American-European Consensus Conference guidelines. Identified patients were followed for 28 days or until death or discharge. None. There were 117 cases of ALI during the study period, giving a population incidence of 2.95/100,000 <16 yrs. ALI accounted for 2.2% of pediatric intensive care unit admissions. Mortality was 35% for ALI, and this accounted for 30% of all pediatric intensive care unit deaths during the study period. Significant preadmission risk factors for mortality were chronic disease, older age, and immunosuppression. Predictors of mortality during admission were ventilatory requirements (peak inspiratory pressures, mean airway pressure, positive end-expiratory pressure) and indexes of respiratory severity on day 1 (Pao2/Fio2 ratio and oxygenation index). Higher maximum and median tidal volumes were associated with reduced mortality, even when corrected for severity of lung disease. Development of single and multiple organ failure was significantly associated with mortality. ALI in children is uncommon but has a high mortality rate. Risk factors for mortality are easily identified. Ventilatory variables and indexes of lung severity were significantly associated with mortality.